secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2023-11-21T23:59:59+00:00
Accession:  0000950170-23-065567
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics receives Nasdaq delisting notice for bid price below $1.00
------------------------------------------------------------------------------

- Nasdaq notified CADL that bid price below $1.00 for 30 consecutive business days.
- Company has 180 days, until May 13, 2024, to regain compliance.
- Compliance requires closing bid price at $1.00 or more for 10 consecutive business days.
- If not compliant, may qualify for second 180-day period by transferring to Nasdaq Capital Market.
- Common stock continues trading on Nasdaq Global Market under CADL; no immediate effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000095017023065567/0000950170-23-065567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000095017023065567/cadl-20231115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-065567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer